Revenues declined 2.1 per cent to Rs 5942 crore in Q2FY22 compared to the previous year's Rs 6069 crore.from Stocks-Markets-Economic Times https://ift.tt/3BVM6VF
Aurobindo Pharma Q2 results: Net profit drops 2.1% YoY to Rs 697 crore
Revenues declined 2.1 per cent to Rs 5942 crore in Q2FY22 compared to the previous year's Rs 6069 crore.from Stocks-Markets-Economic Times https://ift.tt/3BVM6VF
Related Posts:
US stocks claw back much of an early loss and finish mixed- SGX Nifty up 40 points; here's what changed for market while you were sleeping
- AMC, other 'meme' stocks jump; regulator signals concern
- Wall Street body proposes new rules on short positions, stock loans
- Stocks in the news: Religare, BOI, NIA, Petronet LNG, MRF and DHFL
0 Comments:
Post a Comment